title: Cerebropulmonary dysgenetic syndrome.
abstract: Ventilatory treatment of neonatal respiratory distress often results in bronchopulmonary dysplasia from congenital surfactant deficiency due to mutants of transporter protein ABCA3. Association of this condition with other severe disorders in premature newborns has not heretofore been reported. A neonatal autopsy included an in vivo whole blood sample for genetic testing. Autopsy revealed severe interstitial pulmonary fibrosis at age 8 days with heterozygotic mutation p.E292V of ABCA3 and severe dystrophic retardation of cerebral cortex and cerebellum. Subsequently, 1300 archival neonatal autopsies, 1983-2006, were reviewed for comparable concurrent findings and bronchopulmonary dysplasia or retarded cerebral dystrophy lacking the other principal feature of this syndrome. Archival review revealed four similar cases and eight less so, without gene analysis. Further review for bronchopulmonary dysplasia revealed 59 cases, 1983-2006. Several other examples of similar retarded migration of germinal matrix and underdevelopment of cortical mantle, without pulmonary lesions of this type, were identified. The determination of an ABCA3 mutation in one case of severe pulmonary fibrosis with significant dystrophy of the brain and the identification of four highly similar archival cases and eight others with partial pathological findings supports the designation of an independent disorder, here referred to as the cerebropulmonary dysgenetic syndrome.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Tennessee, Memphis 38163, USA. dshanklin@utmem.edu
authors.forename: D Radford
authors.initials: DR
authors.lastname: Shanklin
authors.forename: Amanda C
authors.initials: AC
authors.lastname: Mullins
authors.forename: Heather S
authors.initials: HS
authors.lastname: Baldwin
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D001997:Bronchopulmonary Dysplasia / Q000235:genetics* / Q000473:pathology; D017809:Fatal Outcome; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000235:genetics*; D009154:Mutation; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D013577:Syndrome
chemical_list: C441524:ABCA3 protein, human; D018528:ATP-Binding Cassette Transporters; D011663:Pulmonary Surfactants